PDPN has been reported to identify “a subset of aggressive and radiation-resistant glioblastoma cells” [47] and predict “poor prognosis in patients with glioma” [48] and that it “contributes to constructing immunosuppressive microenvironment in IDH wildtype glioma” [49]. The gene discussed is PDPN; the disease is central nervous system cancer.